M&A

  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer to buy Pacira pain relief device for up to $140M

    Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.

    By • June 30, 2026
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent finalizes Biocare Medical takeover

    The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.

    By • June 26, 2026
  • An image of a surgeon and another clinician in blue scrubs working with a surgical robot.
    Image attribution tooltip
    Courtesy of Karl Storz
    Image attribution tooltip

    Karl Storz laying off employees in North Carolina amid robotics strategy shift

    The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.

    By • June 22, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Medtech M&A maintains momentum following decade-high 2025: PwC

    Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.

    By • June 17, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic closes Scientia Vascular takeover, continuing M&A streak

    CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”

    By • June 15, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Penumbra’s FDA nod for clot removal tech a win for Boston Scientific

    The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.

    By • June 12, 2026
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Danaher closes $9.9B Masimo buyout

    CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.

    By • June 11, 2026
  • A person sits in a white chair and looks to the side.
    Image attribution tooltip
    Elise Reuter/MedTech Dive, data from MedTech Dive
    Image attribution tooltip

    Resmed completes $340M Noctrix takeover

    The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.

    By • June 2, 2026
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech

    The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.

    By • May 27, 2026
  • BioProtect's balloon spacer is shown against a white background.
    Image attribution tooltip
    Courtesy of Olympus
    Image attribution tooltip

    Olympus expands in cancer tech with $270M buy of BioProtect

    BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.

    By • May 26, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to buy SPR Therapeutics for about $650M

    Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

    By • May 20, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Endologix buys clot removal system from Surmodics

    Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.

    By • May 20, 2026
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Artivion closes Endospan buyout to acquire recently approved heart device

    Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.

    By • May 19, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific buys $1.5B stake in TAVR developer MiRus

    The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.

    By • May 18, 2026
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta closes Owen Mumford acquisition for up to $201M

    Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.

    By • May 18, 2026
  • The Stryker logo is displayed on an office building with hills in the background.
    Image attribution tooltip
    JHVEPhoto via Getty Images
    Image attribution tooltip

    Stryker values Amplitude Vascular purchase at up to $835M

    The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.

    By • May 12, 2026
  • A picture of a large building with the name "Stryker" across it and a pond with a swan in the foreground.
    Image attribution tooltip
    Retrieved from Stryker Corporation on January 06, 2025
    Image attribution tooltip

    Stryker closes Amplitude Vascular acquisition

    With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

    By • May 8, 2026
  • A modern office building at the Roche Diagnostics campus features a sleek glass façade with the Roche logo displayed near the entrance, and the structure is surrounded by landscaped greenery.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Roche to acquire digital pathology firm PathAI for up to $1.05B

    Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.

    By • May 7, 2026
  • Professional photo of Joe Almeida
    Image attribution tooltip
    Permission granted by Baxter
    Image attribution tooltip

    Top medtech executive moves in 2026

    Integra LifeSciences has reappointed Stuart Essig as CEO, and Edwards Lifesciences and BD named new CFOs. Read MedTech Dive’s roundup for all the details.

    By MedTech Dive Staff • Updated May 20, 2026
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg

    The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.

    By • April 28, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J to acquire Atraverse Medical

    The FDA-cleared radiofrequency guidewire will slot into J&J’s fast-growing cardiovascular portfolio.

    By • April 27, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic closes $585M purchase of CathWorks

    The deal is the second tuck-in acquisition this year for Medtronic, which has signaled its intent to pursue more M&A in its core business lines.

    By • April 20, 2026
  • A picture of Stereotaxis' GenesisX surgical robot against a white background.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis to buy Robocath for up to $45M

    The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening the company’s position in endovascular surgery, said CEO David Fischel.

    By • April 15, 2026
  • Office workstation top view of business people working around the letters "M&A" as well as a keyboard, calculator, phablet and money on wooden table.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AIP to acquire Avanos Medical in $1.27B go-private deal

    Avanos Medical generated $701.2 million last year from sectors where it competes with Boston Scientific, Medtronic and Stryker.

    By • April 15, 2026
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker to buy Amplitude Vascular Systems

    Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.

    By • April 13, 2026